Barbara Ann Karmanos Cancer Institute

Clinical research site in Detroit, Maine

Part of Barbara Ann Karmanos Cancer Institute

As of July 2026, 1 paid clinical trial is recruiting at Barbara Ann Karmanos Cancer Institute in Detroit, Maine. Active studies at this site focus on Breast Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Barbara Ann Karmanos Cancer Institute (1)

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

for Breast Cancer

20 locations incl. Duarte

Sponsor: Genentech, Inc.

Sex: All·Age: 18+

Code: NCT07100106·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Explore more

Paid clinical trials in Detroit, ME · Maine clinical trials